68Ga-DOTATATE PET/CT Parameters Predict Response to Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumours
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Radiotherapy & Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
68Ga-DOTATATE PET/CT Parameters Predict Response to Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumours
Radiother Oncol 2019 Sep 18;[EPub Ahead of Print], R Sharma, WM Wang, S Yusuf, J Evans, R Ramaswami, F Wernig, A Frilling, F Mauri, A Al-Nahhas, EO Aboagye, TD BarwickFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.